News

Artificial intelligence sign in the United Imaging booth. The Chinese company wants to break into the U.S. market and has a massive booth footprint at RSNA 2023. This included a section for its own AI development division. Photo by Dave Fornell #RSNA
AI briefing: Hyped AI goes to the hospital | Is healthcare AI sustainable? | US & Israel power up AI partnership | more

Just because a healthcare AI product gets loudly promoted doesn’t mean its claims are bogus. The salient question is whether or not it performs as well in a clinical setting as it did in a research lab—or in a marketer’s mind. 

Missouri state house capitol Jefferson City
Missouri becomes latest plaintiff in lawsuits against PBMs, drug companies over skyrocketing insulin prices

The Missouri complaint mirrors those brought by the Federal Trade Commission, the state of Texas and Philadelphia-based Jefferson Health, among others, in that it’s focused on alleged collusion between pharmacy benefit managers and drug companies to control the price of insulin. 

FDA announces Class I recall on anesthesia vaporizers due to risk of chemical exposure

Vapor 2000 and Vapor 3000 devices manufactured by Draegar were improperly cleaned after parts were soldered on, meaning toxic metals could mix with medical gases. Due to the high risk posed to patient health, this recall has earned the FDA’s most serious designation.

warning safety alert recall healthcare issue
FDA issues warning over use of Boston Scientific stents after 167 injuries, 3 deaths

Boston Scientific sent all known customers a letter on December 19, 2025 alerting them to an issue with certain AXIOS Stent and Electrocautery Enhanced Delivery Systems. During deployment, the stents may not expand. This can cause severe, potentially life-threatening injury to patients. All recalled stents must be removed from clinical settings immediately. 

Abbott’s Navitor TAVR valve linked to positive real-world outcomes

The intra-annular, self-expanding Navitor valve gained FDA approval in 2023 for the treatment of high-risk heart patients with severe aortic stenosis. This analysis explores its early impact on patient care. 

Sunil Rao, MD, director, interventional cardiology, cardiac catheterization laboratory, NYU Langone Heart, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, discusses the heart team approach in the context to determining what is best for the patient in terms of bypass surgery or percutaneous coronary intervention.
Heart teams playing a major role in coronary revascularization decisions

Sunil Rao, MD, discusses the heart team approach in the context of deciding what is best for the patient between bypass surgery and percutaneous coronary intervention.

Heart failure experts share guidance on increasing prevention efforts

Cardiology has been shifting from reactionary treatment strategies to a greater emphasis on prevention. This is an especially important trend in heart failure, which is associated with high costs and rising hospitalization rates. 

Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system
FDA confirms recalls for Abbott CGM sensors—new lawsuit alleges company concealed information

The FDA finalized four Class I recalls related to safety concerns first reported by Abbott in November. Meanwhile, a Florida man who uses these sensors to manage his diabetes has already filed a lawsuit over the issue.

ezra
US-based whole-body MRI provider Ezra expands nationwide in UK

Recently acquired by longevity startup Function Health, Ezra is now opening six new imaging sites across the country.

Jocelyn Rapelyea, MD
George Washington University names radiology chair

Jocelyn Rapelyea, MD, completed her residency at the D.C. institution and rose to the rank of professor after years there. 

AI workslop rework
AI roundup: Of workslop and rework | Patent that tech, industry player | Artificial Intellectualism, anyone?

Across industries, more than a third of the time saved by AI gets eaten by overstretched humans who have to clean up the technology’s sloppy work. 

Novel theranostic shows promise for treating gastric and pancreatic cancer
New theranostic could potentially cure difficult-to-treat gastric and pancreatic cancers

Researchers believe new research findings relating to the PET technique signal its potential “to meaningfully change patient care.”

Around the web

Health Exec
AI briefing: Hyped AI goes to the hospital | Is healthcare AI sustainable? | US & Israel power up AI partnership | more

Just because a healthcare AI product gets loudly promoted doesn’t mean its claims are bogus. The salient question is whether or not it performs as well in a clinical setting as it did in a research lab—or in a marketer’s mind. 

Design by Adaptive Theme